0001209191-23-050223.txt : 20230920 0001209191-23-050223.hdr.sgml : 20230920 20230920200930 ACCESSION NUMBER: 0001209191-23-050223 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230918 FILED AS OF DATE: 20230920 DATE AS OF CHANGE: 20230920 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Curet Myriam CENTRAL INDEX KEY: 0001632901 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-24006 FILM NUMBER: 231267579 BUSINESS ADDRESS: STREET 1: 1020 KIFER ROAD CITY: SUNNYVALE STATE: CA ZIP: 94086 BUSINESS PHONE: 408-523-7587 MAIL ADDRESS: STREET 1: 1020 KIFER ROAD CITY: SUNNYVALE STATE: CA ZIP: 94086 FORMER NAME: FORMER CONFORMED NAME: Myriam Curet DATE OF NAME CHANGE: 20150205 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: NEKTAR THERAPEUTICS CENTRAL INDEX KEY: 0000906709 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 943134940 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 455 MISSION BAY BOULEVARD SOUTH CITY: SAN FRANCISCO STATE: CA ZIP: 94158 BUSINESS PHONE: 4154825300 MAIL ADDRESS: STREET 1: 455 MISSION BAY BOULEVARD SOUTH CITY: SAN FRANCISCO STATE: CA ZIP: 94158 FORMER COMPANY: FORMER CONFORMED NAME: INHALE THERAPEUTIC SYSTEMS INC DATE OF NAME CHANGE: 19980723 FORMER COMPANY: FORMER CONFORMED NAME: INHALE THERAPEUTIC SYSTEMS DATE OF NAME CHANGE: 19940303 4 1 doc4.xml FORM 4 SUBMISSION X0508 4 2023-09-18 0 0000906709 NEKTAR THERAPEUTICS NKTR 0001632901 Curet Myriam C/O NEKTAR THERAPEUTICS 455 MISSION BAY BLVD SOUTH, SUITE 100 SAN FRANCISCO CA 94158 1 0 0 0 0 Common Stock 2023-09-18 4 S 0 4359 0.69 D 27418 D Stock Option 0.68 2023-09-19 4 A 0 85000 0.00 A 2031-09-18 Common Stock 85000 85000 D Represents the number of shares required to be sold by the reporting person to cover tax obligations in connection with the vesting of certain RSUs held by the reporting person. This sale is mandated by the reporting person's previous election under the Issuer's equity incentive plans to require the satisfaction of tax obligations to be funded by a "sell to cover" transaction. This stock option vests in equal monthly installments over the one-year period beginning on September 19, 2023. Mark A. Wilson, Attorney-in-Fact 2023-09-20